Development of a Reproducible Prognostic Gene Signature to Predict the Clinical Outcome in Patients with Diffuse Large B-Cell Lymphoma
Crossref DOI link: https://doi.org/10.1038/s41598-019-48721-0
Published Online: 2019-08-21
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zamani-Ahmadmahmudi, Mohamad
Nassiri, Seyed Mahdi
Text and Data Mining valid from 2019-08-21
Version of Record valid from 2019-08-21
Article History
Received: 22 April 2019
Accepted: 6 August 2019
First Online: 21 August 2019
Competing Interests
: The authors declare no competing interests.